Literature DB >> 19155922

ACOG Committee Opinion No. 427: Misoprostol for postabortion care.

.   

Abstract

The World Health Organization estimates that 67,000 women, mostly in developing countries, die each year from untreated or inadequately treated abortion complications. Postabortion care, a term commonly used by the international reproductive health community, refers to a specific set of services for women experiencing problems from all types of spontaneous or induced abortion. There is increasing evidence that misoprostol is a safe, effective, and acceptable method to achieve uterine evacuation for women needing postabortion care. To reduce maternal mortality, availability of postabortion care services must be increased. Misoprostol must be readily available especially for women who do not otherwise have access to postabortion care. Nurses and midwives can safely provide first-line postabortion care services, including in outpatient settings,provided they receive appropriate training and support. Access to contraception and safe abortion services prevents complications from unsafe abortion and decreases the need for postabortion care. It is much less expensive and far better for women's health to prevent the problem of unsafe abortion rather than to treat resulting complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19155922     DOI: 10.1097/AOG.0b013e31819930f9

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  7 in total

1.  Traditional Christian values and women's reproductive rights in modern Russia--is a consensus ever possible?

Authors:  Lyubov Vladimirovna Erofeeva
Journal:  Am J Public Health       Date:  2013-09-12       Impact factor: 9.308

2.  Management of first trimester pregnancy loss can be safely moved into the office.

Authors:  Jana L Allison; Rebecca S Sherwood; Danny J Schust
Journal:  Rev Obstet Gynecol       Date:  2011

3.  [First experience of the use of misoprostol as post-abortion care in Libreville, Gabon].

Authors:  Sosthène Mayi-Tsonga; Ulysse Minkobame; Arielle Mbila; Pamphile Assoumou; Ayisha Diop; Beverly Winikoff
Journal:  Pan Afr Med J       Date:  2014-08-14

4.  Randomised Trial of Oral Misoprostol Versus Manual Vacuum Aspiration for the Treatment of Incomplete Abortion at a Nigerian Tertiary Hospital.

Authors:  Kehinde F Ibiyemi; Munir'deen A Ijaiya; Kikelomo T Adesina
Journal:  Sultan Qaboos Univ Med J       Date:  2019-05-30

5.  Sublingual misoprostol versus manual vacuum aspiration for treatment of incomplete abortion in Nigeria: a randomized control study.

Authors:  Vincent Chinedu Ani; Joseph Tochukwu Enebe; Cyril Chukwudi Dim; Ngozi Regina Dim; Benjamin Chukwuma Ozumba
Journal:  Pan Afr Med J       Date:  2022-02-01

6.  Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries.

Authors:  Tara Shochet; Ayisha Diop; Alioune Gaye; Madi Nayama; Aissata Bal Sall; Fawole Bukola; Thieba Blandine; Okunlola Michael Abiola; Blami Dao; Ogunbode Olayinka; Beverly Winikoff
Journal:  BMC Pregnancy Childbirth       Date:  2012-11-14       Impact factor: 3.007

7.  Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals: implications for task shifting.

Authors:  Nguyen Thi Nhu Ngoc; Tara Shochet; Jennifer Blum; Pham Thanh Hai; Duong Lan Dung; Tran Thanh Nhan; Beverly Winikoff
Journal:  BMC Pregnancy Childbirth       Date:  2013-05-22       Impact factor: 3.007

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.